
JPMorgan Healthcare Leaders ETF
JDOCNASDAQJPMorgan ChaseEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $9.19M
- Expense ratio
- 0.65%
- Dividend yield
- 0.82%
- Holdings
- 65
- 52-week range
- $53.87$64.69
- Volume (live)
- -
- Avg. volume (3M)
- 263
JDOC ETF: JPMorgan Healthcare Leaders ETF - Price, Holdings & Analysis
JPMorgan Healthcare Leaders ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $62.44 - $62.62 |
|---|---|
| 52-Week High | $64.69 |
| 52-Week Low | $53.87 |
| Open | $62.44 |
| Volume (last close) | 2.46K |
| Average Volume (3M) | 263 |
| 1 Day Change | +1.63% |
|---|---|
| 1 Month Change | +1.24% |
| 6 Month Change | +9.04% |
| YTD Change | +7.64% |
| 1 Year Change | +14.06% |
| Annual Dividend | $0.51 |
|---|---|
| Dividend Yield | 0.82% |
| Last Dividend Ex-Date | Dec 16, 2025 |
| Dividend Growth YoY | −81.82% |
| Assets (AUM) | $9.19M |
|---|---|
| Expense Ratio | 0.65% |
| Total Holdings | 65 |
| Inception Date | Oct 31, 2023 |
| 50-Day MA | $61.76 |
|---|---|
| 200-Day MA | $58.72 |
| RSI | 53.43 |
| Stochastic %K | 93.68 |
| Stochastic %D | 58.47 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
JDOC at a Glance
JPMorgan Healthcare Leaders ETF (JDOC) is an equity ETF from JPMorgan Chase, launched in October 2023. It manages $9.19M in assets and charges a 0.65% expense ratio, about $65 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 65 positions. The largest are AbbVie Inc. (ABBV, 8.42%), Eli Lilly and Company (LLY, 7.91%) and Merck & Co., Inc (MRK, 5.43%). The top 10 holdings make up 50.4% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (73.4%), Switzerland (5.9%) and Denmark (5.2%).
It pays distributions yielding 0.82% at the Oct 16, 2026 close, $0.51 per share over the trailing 12 months. As of the Oct 16, 2026 close, the share price is up 14.1% over one year (price change, excluding distributions).
Frequently Asked Questions About JPMorgan Healthcare Leaders ETF
What is the current price of JDOC?
The latest JDOC price is $62.62 (Oct 16, 2026 close). The 52-week range is $53.87–$64.69. The share price is up 14.1% over the past year (price change, excluding distributions).
What is the expense ratio for JDOC?
JDOC's annual expense ratio is 0.65%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does JDOC pay dividends?
Yes, JDOC pays a 0.82% dividend yield (trailing 12 months, at the Oct 16, 2026 close). The most recent ex-dividend date was December 16, 2025. View full dividend history in the Dividends section.
What are the top holdings of JDOC?
As of Oct 4, 2026, JDOC's largest holdings are AbbVie Inc. (8.4%), Eli Lilly and Company (7.9%), Merck & Co., Inc (5.4%) (combined weight: 21.8%). The fund holds 65 total positions. View the complete portfolio breakdown in the Holdings section.
How does JDOC compare to similar ETFs?
Compare JDOC (0.65% expense ratio, $9M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.